SCHEMBL5095400

SCHEMBL5095400

COc1ccc(C(C)=O)c(OC(=O)c2cn(-c3ccccc3)c3ccccc3c2=O)c1

nearest known ligand 0.51

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
NR4A2 P43354 1/20 0.51
TP53 P04637 5/20 0.50
ALDH1A1 P00352 3/20 0.49
HPGD P15428 2/20 0.49
KMT2A Q03164 2/20 0.49
MAPT P10636 2/20 0.49
MEN1 O00255 1/20 0.49
CYP1A2 P05177 1/20 0.49
CYP2C19 P33261 1/20 0.49
RAB9A P51151 1/20 0.49
LMNA P02545 2/20 0.46
CHRM1 P11229 1/20 0.46
KDM4E B2RXH2 2/20 0.46
MTNR1A P48039 1/20 0.45
MTNR1B P49286 1/20 0.45
PLA2G4A P47712 1/20 0.42
HTT P42858 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Acetaldehyde SCHEMBL5095402 0.78 NR4A2 (0.55) NR4A2TP53ALDH1A1KMT2AMAPT
SCHEMBL30309428 0.78 NR4A2 (0.81) NR4A2ALDH1A1KMT2AMEN1LMNA
SCHEMBL28345593 0.78 NR4A2 (0.81) NR4A2ALDH1A1KMT2AMEN1LMNA
SCHEMBL5100977 0.77 NR4A2 (0.51) NR4A2TP53ALDH1A1HPGDKMT2A
SCHEMBL28255059 0.75 TP53 (0.58) NR4A2TP53ALDH1A1HPGDKMT2A
SCHEMBL30292079 0.75 KDM4E (0.59) NR4A2TP53ALDH1A1HPGDKMT2A
SCHEMBL5101006 0.73 NR4A2 (0.59) NR4A2ALDH1A1MAPTLMNAKDM4E
SCHEMBL17176538 0.72 NR4A2 (0.69) NR4A2ALDH1A1KMT2ACYP1A2CYP2C19
SCHEMBL27348299 0.71 KMT2A (0.61) ALDH1A1HPGDKMT2AMAPTMEN1
SCHEMBL11555637 0.71 KDM4E (0.74) NR4A2TP53ALDH1A1HPGDKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7339061-B2 3-(4-oxo-4H-chromen-2-yl)-(1H)-quinolin-4-one derivatives, method for preparing same and pharmaceutical compositions containing same LES LABORATOIRES SERVIER (FR) 2008-03-04 US disclosed
US-20060063801-A1 Novel 3-(4-oxo-4h-chromen-2-yl)-(1H)-quinolin-4-one derivatives, method for preparing same and pharmaceutical compositions containing same LES LABORATOIRES SERVIER (FR) 2006-03-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060063801-A1 Novel 3-(4-oxo-4h-chromen-2-yl)-(1H)-quinolin-4-one derivatives, method for preparing same and pharmaceutical compositions containing same H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, HCCS, RB1 NR4A2 671/4885TP53 71/4885ALDH1A1 543/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.